Emily is a Reader at the Centre for Health Economics and Medicines Evaluation, Chair of the Bangor University Researcher Development & Concordat Group, and an Honorary Research Associate at the Department of Pharmacology and Therapeutics, University of Liverpool.  In 2021 Emily was awarded Health and Care Research Wales Rising Research Star and in 2022 she participated in both the Welsh Crucible and Aurora Leadership Programme for Women.

Emily’s research interests and expertise include preference elicitation and the influence of human behaviour on the cost-effectiveness of interventions.  She currently holds a five-year Health Research Fellowship awarded by Health and Care Research Wales to investigate the economics of rapid diagnostics to reduce antibiotic prescribing in Wales (TRaDe); and is co-lead of the NIHR Grace Project, creating patient-centred infrastructures to enhance informed 
consent and improve patient experience of radiotherapy for gynaecological cancers .  Emily is keen to advance interdisciplinary research of global health concerns.  In 2021 she set-up the Bangor University Antimicrobial Resistance (AMR) Research Interest Group and in 2023 became a founding member of the Wales Active Travel Research Consortium (ATLAS).  Emily also supervises several research students conducting research in preferences for healthcare delivery and benefit-risk assessments of treatments. 

Emily graduated in Economics at the University of Liverpool and started her career at the University of Manchester, before taking her position at Bangor University.  She completed her doctoral research in behavioural economics and health psychology of medication adherence.    Emily has over 70 published papers and conference proceedings and edited health technology assessment reports for the All Wales Therapeutics and Toxicology Centre (AWTTC) for several years.  More recently, she has led on bi-lingual (Welsh & English) public engagement activities for children and adults to learn about Health Economics at National Festivals and University Community Days.  Emily was an inaugural member of the International Society of Medical Adherence Research (ESPACOMP) ECR committee.  Currently, she is a member of the Health and Care Research Wales Faculty and Chair of the Doctoral Fellowship Awards Panel.  She is also a member of the LISTEN, FASAR & GRRAND (NIHR) Trial Steering Committees, Bangor University Athena SWAN working group, and the Bangor University healthcare and medical sciences academic ethics committee review panel.

Ardudwy

Normal Site

Bangor University

Holyhead Road

Bangor

Wales

LL57 2PZ

e-mail: e.holmes@bangor.ac.uk

Tel: +44 (0)1248 382709

Twitter: @EAFHolmes

Web: http://cheme.bangor.ac.uk

Health Research Fellowship

The Economics of Rapid Diagnostics to reduce Antibiotic Prescribing in NHS Wales (TRaDe).

01/10/2020 – 30/09/2025

Principal Investigator:

Patient centred benefit-risk assessment of treatment for colorectal liver metastases in North West England and North Wales (NWCR).

Modelling the health economic outcomes of ‘medicines management of sedating medications’ at HMP Berwyn. A feasibility study (BCUHB).

Developing a protocol and conducting an appropriately powered random-stratified sample of the UK population, to measure changing public attitudes to epilepsy and people with epilepsy (Epilepsy Action).

Cost effectiveness analysis of the use of C reactive protein point of care tests in primary care; a model based on the North Wales pilot project (BCUHB).

Co-investigator:

Developing patient-centred, feasible alternative care for emergency department users with epilepsy. A model for service design (NIHR).

Appointed Research Fellow for Health Economics:

A randomised patient-assessor blinded controlled trial of External non-invasive peripheral nerve stimulation for chronic neuropathic pain following peripheral nerve injury (EN-PENS).

A follow-on study to develop and pilot ‘Seizure first Aid training For Epilepsy’ (SAFE) for people with epilepsy who attend emergency departments, and their family and friends.

Supporting people with type 2 diabetes in effective use of their medicine through a system comprising mobile health technology integrate with clinical care (SUMMiT-D).

CARer-ADministration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients: a UK study (CARiAD).

PhD Supervision:

Lowri Jones.  Understanding and quantifying the public preferences for characteristics of primary dental services in Wales.  Bangor University. 

Ben Lewis. Investigating the Primary Care Dental Workforce Providing National Health Service (NHS) Provision within Wales and the Possible Influences on Recruitment and Retention. Bangor University. 

MPhil Supervision:

Abigail Clynch.  Seizure Control in Glioma-Related Epilepsy: Attribute Selection for a Discrete Choice Experiment.  University of Liverpool. 

MSc Intern Supervision

Elizabeth Rhodes.  Patient focused benefit-harm assessment of ASMs.  University of York.

Short Course Teaching:

Pharmacoeconomics short course, Bangor University. 

Bangor University Researcher Development & Concordat Group Chair. 

Health and Care Research Wales Doctoral and Advanced Fellowship Awards Panel Deputy Chair. 

Member of Bangor University Athena SWAN Task Group (representative for contract research). 

Member of Bangor University Healthcare and Medical Sciences Academic Ethics Committee

NIHR and HCRW Peer-Review

Member of The International Society for Medication Adherence (ESPACOMP) Student Chapter Team (2021-2023)

Member of Epilepsy Action Scientific Awards Panel (2017-2023)

Epilepsy Action Local Services Volunteer